Records containing: Non-valvular Atrial Fibrillation (NVAF)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-09A Prospective, Single-arm Study Evaluating the Endothelialization Effect and Timeline of AnchorMan® Left Atrial Appendage Occluder in Non-valvular Atrial Fibrillation Patients at High Risk of Stroke
-
CLINICAL_TRIALS study record update · 2026-02-04A First-in-Man (FIM) Study of the LAmbre™ II Left Atrial Appendage Occluder and Occluder Delivery System for Patients With Non-Valvular Atrial Fibrillation
-
CLINICAL_TRIALS study record update · 2025-01-08A Real-World, Prospective, Observational Study to Evaluate the Safety and Effectiveness of Rivaroxaban (Xarelto®) for Prevention of Stroke and Systemic Embolism in Indian Patients With Non-valvular Atrial Fibrillation (NVAF)
-
CLINICAL_TRIALS study record update · 2024-12-10A Bioequivalence Study to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety After Administration of IN-R00002 and IN-G00002 in Healthy Adult Volunteers
-
CLINICAL_TRIALS study record update · 2024-11-05The Safety and Effectiveness of Warfarin Vs Apixaban in Patients With Non-Valvular Atrial Fibrillation/ Venous Thromboembolism and End-Stage Kidney Disease on Dialysis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-12-28Xarelto® for the Prevention of Stroke and Noncentral Nervous Systemic Embolism in Non-valvular Atrial Fibrillation With REnal Impairment in Taiwanese Population.
-
CLINICAL_TRIALS study record update · 2023-10-24RENal Outcomes of Rivaroxaban Compared With Warfarin in Asian patienTs With nOn-valvular atRial Fibrillation: a Nationwide Population-based Study
-
CLINICAL_TRIALS study record update · 2023-04-24Optimal Antithrombotic Therapy for Acute Coronary Syndrome Patients Concomitant With Atrial Fibrillation and Implanted With New-generation Drug-eluting Stent: OPTImal Management of Antithrombotic Agents (OPTIMA-3, 4)
-
CLINICAL_TRIALS study record update · 2022-12-08Xarelto® on Prevention of Stroke and Non-Central Nervous Systemic (CNS) Embolism in Renally Impaired Korean Patients With Non-valvular Atrial Fibrillation (NVAF)
-
CLINICAL_TRIALS study record update · 2022-07-19Factor XA - Inhibition in RENal Patients With Non-valvular Atrial Fibrillation - Observational Registry
-
CLINICAL_TRIALS study record update · 2022-06-24AMPLATZER™ Cardiac Plug Observational Post-Approval Study
-
CLINICAL_TRIALS study record update · 2019-05-30Treatment Satisfaction Under Rivaroxaban (ACTS/TSQM)
-
CLINICAL_TRIALS study record update · 2016-08-17Early Post-marketing Study of Eliquis (Apixaban)